Risk factor clustering in the insulin resistance syndrome. The strong heart study

American Journal of Epidemiology

Volumn 148, Issue 9, 1998, Pages 869-878

  Gray, R Stuart ^a   Fabsitz, Richard R ^b   Cowan, Linda D ^c   Lee, Elisa T ^c   Howard, Barbara V ^a   Savage, Peter J ^b  

^a Medlantic Research Institute   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Coronary disease; Factor analysis; Indians; Insulin resistance; North American; Statistical

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; UNITED STATES;

EID: 3543110722     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009712     Document Type: Article

References (41)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. Denker PS, Pollock VE. Fasting serum insulin levels in essential hypertension. Arch Intern Med 1992;152:1649-51.
3. Selby JV, Austin MA, Newman B, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:381-7.
4. Groop L, Ekstrand A, Forsblom C, et al. Insulin resistance, hypertension, and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36:642-7.
5. Vague P, Juhan-Vague I. Insulin and the fibrinolytic system. A link between metabolism and thrombogenesis. In: Smith U, Bruun NE, Hedner T, et al, eds. Hypertension as an insulin-resistant disorder. Genetic factors and cellular mechanisms. Amsterdam: Excerpta Medica, 1991:321-34. (International Congress series 980).
6. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuncemia and insulin resistance. J Clin Endocrinol Metab 1994;78:25-9.
7. La Rosa JC, Hunninghake D, Bush D, et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation 1990;81:1721-33.
8. Pyorala K. Relationship of glucose tolerance and plasma insulin in the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2: 131-41.
9. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2:154-60.
10. Ducimetiere P, Eschwege E, Papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980;19:205-10.
11. Saad MF, Lilioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991;324:733-9.
12. Howard BV, Lee ET, Yeh JL, et al. Hypertension in adult American Indians-the Strong Heart Study. Hypertension 1996; 28:256-64.
13. Collins VR, Dowse GK, Finch CF, et al. An inconsistent relationship between insulin and blood pressure in three Pacific island populations. J Clin Epidemiol 1990;43:1369-78.
14. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-74.
15. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
16. Stevens J. Applied multivariate statistics for the social sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1986:337-50.
17. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariate methods. Boston, MA: Kent Publishing Co, 1988.
18. Edwards KL, Austin MA, Newman B, et al. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 1994;14:1940-5.
19. Austin MA, Mykkanen L, Kuusisto J, et al. Prospective study of small LDLs as a risk factor for non-insulin-dependent diabetes mellitus in elderly men and women. Circulation 1995;92:1770-8.
20. Wingard D, Von Muhlen D, Barrett-Connor E, et al. Factor analysis of proposed components of the insulin resistance syndrome. Presented at the 56th Scientific Sessions of the American Diabetes Association, San Francisco, California, June 8-11, 1996.
21. Meigs JB, D'Agostino RB, Cupples A, et al. Evidence that insulin resistance does not unify metabolic cardiovascular disease risk variable clustering: the Framingham Offspring Study. Presented at the 56th Scientific Sessions of the American Diabetes Association, San Francisco, California, June 8-11, 1996.
22. Lee ET, Welty TK, Fabsitz RR, et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990;132:1141-55.
23. Howard BV, Welty TK, Fabsitz RR, et al. Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans: the Strong Heart Study. Diabetes 1992;41:4-11.
24. Stoddart M, Jarvis B, Blake B, et al. Recruitment of American Indians in epidemiologic research - the Strong Heart Study. In: Proceedings of the 121st Annual Meeting of the American Public Health Association, San Francisco, California, October 1993.
25. Morgan C, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic, and diabetic rats. Diabetes 1963;12:115-26.
26. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings. Littleton, MA: John Wright PSC, 1982.
27. Rose GA, Blackburn H. Cardiovascular survey methods. 2nd ed. Geneva, Switzerland: World Health Organization, 1982. (Monograph series no. 56 G).
28. WHO Expert Committee on Diabetes Mellitus. Second report. Geneva, Switzerland: World Health Organization, 1980. (Technical report series 646).
29. Cooper JCB. Factor analysis: an overview. Am Statistician 1983;37:141-7.
30. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65.
31. Nagulesparen M, Savage PJ, Under RH, et al. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes 1979;28:980-3.
32. Welty TK, Lee ET, Yeh J, et al. Cardiovascular disease risk factors among American Indians: the Strong Heart Study. Am J Epidemiol 1995;142:269-87.
33. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
34. Criqui MH, Browner D, Fronek A, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989;129:1110-19.
35. Fowkes FGR, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischaemic heart disease in the Edinburgh artery study. Am J Epidemiol 1992; 135:331-40.
36. Manolio TA, Savage PJ, Burke GL, et al. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA Study. Arteriosclerosis 1990; 10:430-6.
37. Howard BV, Lee ET, Cowan LD, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995;142:254-68.
38. Fabsitz RR, Sidawy AN, Go O, et al. Peripheral arterial disease prevalence and associated risk factors in American Indians. The Strong Heart Study. Am J Epidemiol (in press).
39. Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993;9:452-9.
40. Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein levels: the Framingham Study. JAMA 1986;256:2835-8.
41. Bogardus C. Insulin resistance in the pathogenesis of NIDDM in Pima Indians. Diabetes Care 1993;16:228-31.